189 related articles for article (PubMed ID: 23295552)
21. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
22. Imaging techniques in cardiac resynchronization therapy.
Sá MI; de Roos A; Westenberg JJ; Kroft LJ
Int J Cardiovasc Imaging; 2008 Jan; 24(1):89-105. PubMed ID: 17503216
[TBL] [Abstract][Full Text] [Related]
23. New diagnostic perspectives on heart failure with preserved ejection fraction: systolic function beyond ejection fraction.
Todaro MC; Khandheria BK; Longobardo L; Zito C; Cusmà-Piccione M; Di Bella G; Oreto L; Mohammed M; Oreto G; Carerj S
J Cardiovasc Med (Hagerstown); 2015 Aug; 16(8):527-37. PubMed ID: 25469729
[TBL] [Abstract][Full Text] [Related]
24. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
[TBL] [Abstract][Full Text] [Related]
25. Imaging for implementation of heart failure guidelines.
Nagueh SF; Nabi F; Chang SM; Al-Mallah M; Shah DJ; Bhimaraj A
Eur Heart J Cardiovasc Imaging; 2023 Sep; 24(10):1283-1292. PubMed ID: 37418490
[TBL] [Abstract][Full Text] [Related]
26. Implications of coronary artery disease in heart failure with preserved ejection fraction.
Hwang SJ; Melenovsky V; Borlaug BA
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
[TBL] [Abstract][Full Text] [Related]
27. [Heart failure I: Clinical aspects, causes. diagnostic strategies].
Morf S; Hochuli M; Elke B; Noll G
Praxis (Bern 1994); 2009 Dec; 98(25):1483-90; quiz 1491-2. PubMed ID: 20013682
[No Abstract] [Full Text] [Related]
28. Echocardiography in 2009: the future of clinical diagnosis.
Nihoyannopoulos P
Future Cardiol; 2010 Jan; 6(1):37-49. PubMed ID: 20014986
[TBL] [Abstract][Full Text] [Related]
29. The role of cardiovascular magnetic resonance imaging in heart failure.
Karamitsos TD; Francis JM; Myerson S; Selvanayagam JB; Neubauer S
J Am Coll Cardiol; 2009 Oct; 54(15):1407-24. PubMed ID: 19796734
[TBL] [Abstract][Full Text] [Related]
30. Diastolic dysfunction: improved understanding using emerging imaging techniques.
Daneshvar D; Wei J; Tolstrup K; Thomson LE; Shufelt C; Merz CN
Am Heart J; 2010 Sep; 160(3):394-404. PubMed ID: 20826245
[TBL] [Abstract][Full Text] [Related]
31. Clinical applications of cardiac magnetic resonance imaging.
Pilz G; Heer T; Harrer E; Ali E; Hoefling B
Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
[TBL] [Abstract][Full Text] [Related]
32. Emerging role of cardiac computed tomography in heart failure.
Aziz W; Claridge S; Ntalas I; Gould J; de Vecchi A; Razeghi O; Toth D; Mountney P; Preston R; Rinaldi CA; Razavi R; Niederer S; Rajani R
ESC Heart Fail; 2019 Oct; 6(5):909-920. PubMed ID: 31400060
[TBL] [Abstract][Full Text] [Related]
33. Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure.
Aurigemma GP; Zile MR; Gaasch WH
Am Heart J; 2004 Sep; 148(3):E12. PubMed ID: 15389248
[TBL] [Abstract][Full Text] [Related]
34. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.
Iles L; Pfluger H; Phrommintikul A; Cherayath J; Aksit P; Gupta SN; Kaye DM; Taylor AJ
J Am Coll Cardiol; 2008 Nov; 52(19):1574-80. PubMed ID: 19007595
[TBL] [Abstract][Full Text] [Related]
36. Established and emerging cardiovascular magnetic resonance techniques for prognostication and guiding therapy in heart failure.
Swoboda PP; Plein S
Expert Rev Cardiovasc Ther; 2014 Jan; 12(1):45-55. PubMed ID: 24345093
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging assessment of intraventricular dyssynchrony and delayed enhancement as predictors of response to cardiac resynchronization therapy in patients with heart failure of ischaemic and non-ischaemic etiologies.
Petryka J; Miśko J; Przybylski A; Śpiewak M; Małek ŁA; Werys K; Mazurkiewicz Ł; Gepner K; Croisille P; Demkow M; Rużyłło W
Eur J Radiol; 2012 Oct; 81(10):2639-47. PubMed ID: 22056486
[TBL] [Abstract][Full Text] [Related]
38. The role of echocardiography in hemodynamic assessment in heart failure.
Abraham J; Abraham TP
Heart Fail Clin; 2009 Apr; 5(2):191-208. PubMed ID: 19249688
[TBL] [Abstract][Full Text] [Related]
39. [Does echocardiography have any role in selecting patients for cardiac resynchronization therapy?].
Gazzaniga P; Tovena DM; Nanetti M; Rizzini AL; Foffa A; Inama G
G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):130S-133S. PubMed ID: 21416843
[TBL] [Abstract][Full Text] [Related]
40. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
